JJ
J&J pay $9.9 million to settle surgical mesh implant case
April 23, 2019Manufacturing and Production . Johnson & Johnson, J&J, JJ, Johnson & Johnson, Litigation, washington
Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s …
Janssen closes plant in California, 49 positions axed
April 3, 2019Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, Vacaville, california
Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California. The Johnson & …
Indian authorities say J&J’s baby shampoo contains ‘harmful ingredients’
April 1, 2019Sales and Marketing Cancer, India, J&J, JJ, Johnson & Johnson, Rajasthan, baby shampoo, formaldehyde
Indian authorities in the state of Rajasthan have said that samples taken from Johnson & Johnson’s baby shampoo contained ‘harmful …
J&J’s antihistamine-releasing contact lens shows promise in Phase 3 trials
March 28, 2019Research and Development J&J, JJ, eye care, pharma
Johnson and Johnson has unveiled new Phase 3 data on its antihistamine-releasing contact lens, showing that the investigational product led …
J&J bows to PETA pressure and drops forced swim tests in mice
March 21, 2019Medical Communications J&J, JJ, Johnson & Johnson, PETA, animal welfare, pharma
Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other …
J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments
March 1, 2019Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology
Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …
Missouri Supreme Court ruling could help J&J in talc cases
February 25, 2019Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc
The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts …
US Department of Justice investigate J&J over Baby Powder allegations
February 22, 2019Medical Communications Cancer, J&J, JJ, Johnson and Johnson, USA, asbestos, oncology, talc
The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …
J&J acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal
February 14, 2019Manufacturing and Production, Research and Development, Sales and Marketing Auris Health, Cancer, J&J, JJ, lung cancer, pharma, robotics
In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics …
J&J to include prices in drug ads on TV
February 8, 2019Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing
US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …
Pharma chiefs will testify at Senate hearing on rising drug prices
February 7, 2019Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …
J&J joins in on industry price hiking; almost 500 drug prices increased in 2019 so far
January 11, 2019Medical Communications, Sales and Marketing J&J, JJ, Stelara, US, Xarelto, Zytiga, pharma, price hikes
It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …
J&J’s Baby powder tested in India and Bangladesh
December 21, 2018Medical Communications Bangladesh, Cancer, India, J&J, JJ, asbestos
Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after …
Indian authorities seize J&J Baby Powder in response to Reuters report
December 19, 2018Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …
J&J announces $5bn share repurchase
December 18, 2018Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
